Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
CC transcript
Asset disposition
Cert. of designation
Director departure
Appointed director
|
|
ALIMERA SCIENCES INC (ALIM)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/16/2023 |
SC 13D/A
| Velan Capital Investment Management LP reports a 26% stake in Alimera Sciences, Inc. |
| 08/03/2023 |
SC 13D/A
| Caligan Partners LP reports a 33.1% stake in Alimera Sciences, Inc. |
| 08/03/2023 |
SC 13D/A
| Velan Capital Investment Management LP reports a 26% stake in Alimera Sciences, Inc. |
| 05/19/2023 |
SC 13D/A
| Velan Capital Investment Management LP reports a 18.9% stake in Alimera Sciences, Inc. |
| 05/18/2023 |
SC 13D/A
| Caligan Partners LP reports a 10% stake in Alimera Sciences, Inc. |
| 03/28/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/29/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/14/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/24/2020 |
SC 13D/A
| CHEZ RONALD L reports a 7% stake in ALIMERA SCIENCES, INC. |
| 02/14/2019 |
SC 13D/A
| POLARIS VENTURE PARTNERS IV LP reports a 4.4% stake in Alimera Sciences, Inc. |
| 06/08/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/12/2016 |
SC 13D/A
| Sofinnova Venture Partners VIII, L.P. reports a 4.8% stake in Alimera Sciences, Inc. |
| 02/14/2012 |
SC 13D/A
| ALIMERA SCIENCES INC reports a 10.3% stake in Alimera Sciences, Inc. |
| 06/03/2011 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
|
|